Stevens Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Stevens Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,249	Closed	-$93K	–	1298
2015 Q2	$93K	Buy	+10,249	New	+$103K	﹤0.01%	959
2014 Q2	–	Sell	-13,295	Closed	-$132K	–	1385
2014 Q1	$132K	Buy	+13,295	New	+$165K	﹤0.01%	982

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stevens Capital Management's GNMK Position: Q3 2015 in Review

Stevens Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2015, closing a stake of 10,249 shares — an estimated $93K sold.

Stevens Capital Management first reported a position in GNMK in Q1 2014 and held it in 2 quarters. The position peaked at $132K in Q1 2014. 88 funds tracked by Wall St. Rank hold GNMK as of Q3 2015.

Stevens Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q3 2015 after selling out during the quarter.
Stevens Capital Management sold 10,249 GenMark Diagnostics, Inc shares in Q3 2015, an estimated $93K.
Stevens Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2014 and held it in 2 quarters.
Stevens Capital Management's GenMark Diagnostics, Inc position peaked at $132K in Q1 2014.
88 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2015.

Based on Stevens Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.